The present disclosure provides a method of treating colitis and colorectal cancer with a m-calpain selective inhibitor. Also described in this disclosure are pharmaceutical compositions comprising a m-calpain selective inhibitor to inhibit m-calpain activity in tumor cells and other cells in the colon.